Opinion
AI, biotech, and federal investment a generational opportunity for NC’s research universities
This is not possible without a steadfast commitment from our partners in the federal government and private industry. It’s important to acknowledge and evaluate the current constraints. On the ...
STERIS plc, a global provider of products and services that support patient care with an emphasis on infection prevention, plans to invest $600 million to build a new facility in Sanford, creating 335 ...
This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To ...
Celebrating its 11th year, LEAD Conference 2026 will gather visionary leaders from industry, higher education, community colleges, government agencies, nonprofits, and economic development ...
Genentech, considered one of the biotech industry’s founding companies, announced in May 2025 that it planned to build a $700 million, 700,000-square-foot manufacturing facility in Holly Springs and ...
West Pharmaceutical Services, a Pennsylvania-based manufacturer of drug-packaging and delivery components in the Eastern North Carolina community of Kinston for the last four decades, will invest ...
Our main lobby, or Galleria, is a beautiful space highlighted by soaring 40-foot ceilings, loads of natural light, and gleaming hardwood floors. The Galleria is home to our guest services desk and is ...
NCBiotech is working with statewide partners to drive strategy and support the CRO sector. By working together to expand the clinical-based workforce and awareness of the CRO community, North Carolina ...
UNC Charlotte's Invention of the Year Awards honor faculty and students' groundbreaking inventions in life sciences, energy, data and materials. By attending, judging, or sponsoring, your involvement ...
Durham-based Atsena Therapeutics, a clinical-stage gene therapy company focused on using genetic medicine to reverse or prevent blindness, has dosed the first patient in the Phase 3 pivotal cohort of ...
This year’s summit will feature an industry-leading speaker lineup exploring some of the most important topics shaping the industry: ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results